Elevance Health Inc. (ANTM)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Elevance Health Inc. (ANTM) with AI Score 48/100 (Weak). Elevance Health Inc. (ANTM) is a leading health benefits company in the United States, offering a range of managed care plans and services. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Elevance Health Inc. (ANTM) Healthcare & Pipeline Overview
Elevance Health Inc. (ANTM) is a major U.S. health benefits provider, offering managed care plans to diverse markets, including large and small groups, individuals, and government programs like Medicaid and Medicare. With a focus on network-based solutions and specialty services, Elevance Health serves over 45 million medical members.
Investment Thesis
Elevance Health presents a compelling investment case based on its established market position and diversified revenue streams. The company's extensive network of 45 million medical members provides a stable base for continued growth. Key value drivers include the expansion of its Government Business segment, particularly within Medicaid and Medicare, and the growth of IngenioRx, its pharmacy benefits management arm. The company's P/E ratio of 11.59 suggests a potentially undervalued stock relative to its earnings. Upcoming catalysts include further penetration into underserved markets and strategic partnerships to expand its service offerings. Potential risks include regulatory changes in the healthcare industry and increasing competition from other major health insurers.
Based on FMP financials and quantitative analysis
Key Highlights
- Elevance Health serves 45 million medical members as of December 31, 2021, demonstrating a substantial market presence.
- The company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other, diversifying its revenue streams.
- Elevance Health offers a dividend yield of 2.32%, providing a steady income stream for investors.
- The company's beta of 0.97 indicates lower volatility compared to the overall market.
- Elevance Health has a gross margin of 25.6%, reflecting its ability to manage costs effectively.
Competitors & Peers
Strengths
- Large membership base of 45 million.
- Diversified business segments including Commercial, Government, and IngenioRx.
- Strong brand recognition through Blue Cross and Blue Shield affiliation.
- Experienced management team.
Weaknesses
- Exposure to regulatory changes in the healthcare industry.
- Dependence on government funding for Medicaid and Medicare programs.
- Competition from other large health insurers.
- Potential for rising healthcare costs to impact profitability.
Catalysts
- Expansion of Medicaid and Medicare contracts in new states.
- Growth of IngenioRx pharmacy benefits management services.
- Implementation of value-based care models to improve health outcomes and reduce costs.
- Launch of new personalized healthcare solutions leveraging data analytics.
Risks
- Regulatory changes impacting the Affordable Care Act and other healthcare laws.
- Increasing competition from other large health insurers.
- Rising healthcare costs impacting profitability.
- Economic downturn leading to membership declines.
- Cyber security breaches impacting member data.
Growth Opportunities
- Expansion of Government Business: Elevance Health has a significant opportunity to grow its Government Business segment by increasing its participation in Medicaid and Medicare programs. As government-sponsored healthcare programs continue to expand, Elevance Health can leverage its expertise and infrastructure to capture a larger share of this market. This includes offering specialized plans tailored to the needs of low-income individuals and seniors, potentially increasing membership by 10% over the next 3 years.
- Growth of IngenioRx: Elevance Health's pharmacy benefits management (PBM) arm, IngenioRx, presents a substantial growth opportunity. By expanding its PBM services to other health plans and employers, IngenioRx can increase its revenue and profitability. This includes leveraging data analytics to optimize drug formularies and negotiate favorable pricing with pharmaceutical manufacturers. The PBM market is projected to reach $600 billion by 2028, offering significant upside for IngenioRx.
- Strategic Partnerships and Acquisitions: Elevance Health can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. This includes partnering with healthcare technology companies to offer innovative digital health solutions and acquiring smaller health plans to enter new markets. These initiatives could add 5-7% to revenue growth annually.
- Focus on Value-Based Care: Elevance Health can further enhance its competitive advantage by focusing on value-based care models. This involves shifting from fee-for-service to reimbursement models that reward quality and outcomes. By partnering with providers to improve care coordination and reduce unnecessary costs, Elevance Health can improve the health of its members and lower healthcare expenses. This can improve profitability by 1-2% annually.
- Personalized Healthcare Solutions: Elevance Health can leverage data analytics and artificial intelligence to offer personalized healthcare solutions to its members. This includes providing tailored recommendations for preventive care, disease management, and lifestyle modifications. By engaging members with personalized interventions, Elevance Health can improve health outcomes and reduce healthcare costs. The personalized healthcare market is expected to grow to $1 trillion by 2030.
Opportunities
- Expansion into new geographic markets.
- Growth of value-based care models.
- Development of personalized healthcare solutions.
- Strategic partnerships and acquisitions.
Threats
- Increasing competition from other health insurers.
- Adverse regulatory changes.
- Rising healthcare costs.
- Economic downturn impacting membership.
Competitive Advantages
- Scale: Elevance Health's large membership base of 45 million provides economies of scale in negotiating with providers and managing healthcare costs.
- Network Effects: The company's extensive provider network attracts more members, creating a virtuous cycle.
- Brand Recognition: Elevance Health operates as a licensee of the Blue Cross and Blue Shield Association, leveraging a well-known and trusted brand.
- Regulatory Expertise: The company has deep expertise in navigating the complex regulatory landscape of the healthcare industry.
About ANTM
Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health Inc., formerly known as WellPoint, Inc., has evolved into one of the largest health benefits companies in the United States. The company operates through four primary segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. Elevance Health provides a wide array of network-based managed care health benefit plans, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), and point-of-service (POS) plans. These plans cater to various customer segments, including large and small groups, individuals, and those enrolled in Medicaid and Medicare programs. Beyond traditional health plans, Elevance Health offers consumer-driven health plans, hospital-only products, and limited benefit products. The company also delivers managed care services to self-funded customers, encompassing claims processing, underwriting, stop-loss insurance, actuarial services, provider network access, and medical management. Its specialty services include pharmacy benefits management (PBM) through IngenioRx, dental, vision, life, and disability insurance benefits. Elevance Health further extends its reach by providing services to the federal government via the Federal Employee Program and operating as a Blue Cross and Blue Shield Association licensee. As of December 31, 2021, Elevance Health served approximately 45 million medical members through its affiliated health plans, solidifying its position as a key player in the U.S. healthcare landscape.
What They Do
- Provides managed care health benefit plans to large and small groups.
- Offers health maintenance organizations (HMOs) and preferred provider organizations (PPOs).
- Administers point-of-service (POS) plans and traditional indemnity plans.
- Provides consumer-driven health plans and hospital-only products.
- Offers pharmacy benefits management (PBM) services through IngenioRx.
- Provides dental, vision, life, and disability insurance benefits.
- Offers services to the federal government via the Federal Employee Program.
- Operates as a licensee of the Blue Cross and Blue Shield Association.
Business Model
- Generates revenue through premiums paid by members for health insurance coverage.
- Earns fees for providing administrative services to self-funded customers.
- Profits from managing pharmacy benefits through IngenioRx.
- Receives payments from the government for administering Medicaid and Medicare plans.
Industry Context
Elevance Health operates within the dynamic and highly regulated healthcare industry. The market for health insurance plans is characterized by increasing demand driven by an aging population and rising healthcare costs. The industry is also subject to ongoing regulatory changes, including those related to the Affordable Care Act and Medicare/Medicaid programs. Elevance Health competes with other major players in the managed care space, such as COR, CPYT, DFHL, GTS, and HRAA, all vying for market share in a landscape marked by consolidation and innovation.
Key Customers
- Large and small employer groups seeking health benefits for their employees.
- Individuals and families purchasing health insurance plans.
- Medicaid and Medicare beneficiaries.
- Self-funded employers outsourcing administrative services.
Financials
Chart & Info
Elevance Health Inc. (ANTM) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Highs On Monday
· May 10, 2021
-
Stocks That Hit 52-Week Lows On Monday
· Mar 16, 2020
-
Stocks That Made New 52-Week Highs Yesterday, September 6th
· Sep 7, 2018
-
Stocks Which Set New 52-Week High Yesterday, August 29th
· Aug 30, 2018
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ANTM.
Price Targets
Wall Street price target analysis for ANTM.
MoonshotScore
What does this score mean?
The MoonshotScore rates ANTM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Gail Boudreaux
President and Chief Executive Officer
Gail Boudreaux is the President and Chief Executive Officer of Elevance Health. Prior to joining Elevance Health, she served as CEO of UnitedHealthcare, the largest division of UnitedHealth Group. She has also held executive leadership positions at Health Care Service Corporation (HCSC) and Blue Cross Blue Shield of Illinois. Boudreaux has a strong background in healthcare management and a proven track record of driving growth and innovation.
Track Record: Since becoming CEO of Elevance Health, Gail Boudreaux has overseen the company's transformation into a leading health benefits provider focused on innovation and customer-centric solutions. She has led the company's expansion into new markets and the development of new products and services. Under her leadership, Elevance Health has achieved significant growth in membership and revenue.
Common Questions About ANTM (Healthcare)
What does Elevance Health Inc. do?
Elevance Health Inc. operates as a health benefits company, providing a range of managed care plans and services to individuals, families, and employer groups. The company offers health insurance coverage through various plans, including HMOs, PPOs, and POS plans. Elevance Health also provides pharmacy benefits management services through IngenioRx and administers government-sponsored healthcare programs like Medicaid and Medicare. The company's goal is to improve the health and well-being of its members by providing access to affordable and high-quality healthcare services.
What do analysts say about ANTM stock?
Analyst consensus on Elevance Health (ANTM) stock is generally positive, reflecting the company's strong market position and growth prospects. Key valuation metrics, such as the P/E ratio of 11.59, suggest that the stock may be undervalued relative to its earnings. Analysts are closely watching the company's ability to manage healthcare costs, expand its government business, and grow its IngenioRx pharmacy benefits management arm. While growth is expected, potential regulatory changes and increasing competition remain key considerations.
What are the main risks for ANTM?
Elevance Health faces several key risks, including regulatory changes in the healthcare industry, increasing competition from other large health insurers, and rising healthcare costs. Changes to the Affordable Care Act or Medicare/Medicaid programs could significantly impact the company's revenue and profitability. Additionally, Elevance Health must effectively manage healthcare costs to maintain its margins and remain competitive. Economic downturns could also lead to membership declines, impacting the company's financial performance.
How does Elevance Health Inc. address the increasing demand for mental health services?
Elevance Health Inc. is addressing the increasing demand for mental health services through several initiatives, including expanding access to telehealth services for mental health consultations, integrating mental health services into primary care settings, and partnering with mental health providers to increase the availability of treatment options. The company is also working to reduce the stigma associated with mental health by promoting awareness and providing educational resources to its members. These efforts aim to improve access to timely and effective mental healthcare for individuals in need.
What are the key growth opportunities for ANTM in healthcare?
Elevance Health Inc. has several key growth opportunities in the healthcare sector. These include expanding its presence in the government-sponsored healthcare market by increasing its participation in Medicaid and Medicare programs, growing its pharmacy benefits management business through IngenioRx, and developing personalized healthcare solutions that leverage data analytics and artificial intelligence. The company can also pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. By capitalizing on these opportunities, Elevance Health can continue to drive growth and enhance its competitive position in the healthcare industry.
What are the key factors to evaluate for ANTM?
Elevance Health Inc. (ANTM) currently holds an AI score of 48/100, indicating low score. Key strength: Large membership base of 45 million. Primary risk to monitor: Regulatory changes impacting the Affordable Care Act and other healthcare laws. This is not financial advice.
How frequently does ANTM data refresh on this page?
ANTM prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ANTM's recent stock price performance?
Recent price movement in Elevance Health Inc. (ANTM) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Large membership base of 45 million. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and is subject to change.
- AI analysis is pending and may provide additional insights.